S&P 500 Futures
(0.11%) 5 333.00 points

Dow Jones Futures
(0.04%) 40 155 points

Nasdaq Futures
(0.18%) 18 669 points

Oil
(0.29%) $80.29

Gas
(1.03%) $2.65

Gold
(1.13%) $2 444.60

Silver
(2.96%) $32.19

Platinum
(-0.05%) $1 089.50

USD/EUR
(-0.01%) $0.920

USD/NOK
(-0.03%) $10.67

USD/GBP
(0.09%) $0.788

USD/RUB
(-0.41%) $90.60

Realtime updates for Evgen Pharma PLC [EVG.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences

Last Updated24 Apr 2024 @ 11:24

25% discount on Stockinvest.us - Use code: Podcast

0.00% £ 0.800

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 11:24):

Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases...

Stats
Today's Volume	10.75M
Average Volume	1.27M
Market Cap	3.42M
EPS	£0 ( 2024-04-19 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.800
ATR14	£0 (0.00%)

Evgen Pharma PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Evgen Pharma PLC Financials

Annual	2022
Revenue:	£442 000
Gross Profit:	£429 000 (97.06 %)
EPS:	£-0.0147

FY	2022
Revenue:	£442 000
Gross Profit:	£429 000 (97.06 %)
EPS:	£-0.0147

FY	2022
Revenue:	£0
Gross Profit:	£0 (0.00 %)
EPS:	£-0.00990

FY	2021
Revenue:	£194 000
Gross Profit:	£0.00 (0.00 %)
EPS:	£-0.0279

Financial Reports:

No articles found.

Evgen Pharma PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Evgen Pharma PLC

Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.